Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep 8;13(9):e17829.
doi: 10.7759/cureus.17829. eCollection 2021 Sep.

Turmeric as a Possible Treatment for COVID-19-Induced Anosmia and Ageusia

A Bert Chabot  1 , Margaret P Huntwork  2
Affiliations
Case Reports

Turmeric as a Possible Treatment for COVID-19-Induced Anosmia and Ageusia

A Bert Chabot et al. Cureus. .

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has caused a calamitous perturbation of society worldwide. Anosmia and ageusia (or hyposmia and dysgeusia) have been recognized as two common expressions of COVID-19 infection that linger for days to weeks, and in rare cases are thought to be immutable. Time alone has hitherto proven most effective in their restoration, but turmeric, long believed by some to have medicinal properties, may be a swifter and surer alleviator of anosmia and ageusia. This case series reports the speedy and consequential restoration of taste and smell in two subjects infected with COVID-19 following ingestion of one 1000 mg dose of a turmeric supplement. In view of this, we propose that turmeric be considered in the treatment of anosmia and ageusia caused by COVID-19 infection.

Keywords: ageusia; anosmia; coronavirus; covid-19; curcumin; dysgeusia; hyposmia; sars-cov-2; turmeric.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Vaira LA, Salzano G, Fois AG, Piombino P, De Riu G. Int Forum Allergy Rhinol. 2020;10:1103–1104. - PMC - PubMed
    1. Olfactory and gustatory outcomes in COVID- 19: a prospective evaluation in nonhospitalized subjects. Paderno A, Mattavelli D, Rampinelli V, et al. Otolaryngol Head Neck Surg. 2020;163:1144–1149. - PMC - PubMed
    1. Prognosis of postviral olfactory loss: follow-up study for longer than one year. Lee DY, Lee WH, Wee JH, Kim JW. Am J Rhinol Allergy. 2014;28:419–422. - PubMed
    1. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Meinhardt J, Radke J, Dittmayer C, et al. Nat Neurosci. 2021;24:168–175. - PubMed
    1. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Brann DH, Tsukahara T, Weinreb C, et al. Sci Adv. 2020;6:5801. - PMC - PubMed

Publication types

LinkOut - more resources